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Objectives:  To measure the levels of glutamate, a major excitatory neurotransmitter; 
glutamine, a metabolite of glutamate; and γ-aminobutyric acid (GABA), a major inhibitory 
neurotransmitter; in a pilot study of proton magnetic resonance spectroscopy (1H-MRS) findings 
in adolescents with Autism Spectrum Disorders (ASD).  
Methods:   The subjects were assessed with the Autism Diagnostic Observation Schedule 
(ADOS), the Reading the Mind in the Eyes test (RMET) and the Social Responsiveness Scale 
(SRS). 1H-MRS measures of the anterior cingulate cortex were conducted using a Philips 3.0 
T scanner.   
Results: To date, we have completed the data analysis on 18 subjects, 8 with ASD and 10 
healthy control (HC) subjects. There was no significant difference between the combined 
glutamate + glutamine concentrations as measured by 1H-MRS (ASD = 12.0 ± 0.9 IU, HC = 
11.6 ± 0.8 IU, p = 0.37). However, there was a higher than average glutamine level in the ASD 
group compared to healthy controls (ASD = 2.4 ± 0.2 IU, HC = 1.9 ± 0.3 IU, p = 0.01). This was 
accompanied by a trend toward lower GABA/Cr levels in the ASD group (ASD = 0.073 ± 0.010, 
HC = 0.082 ± 0.010, p = 0.06). Glutamine levels in the ACC were correlated positively with 
deficits of social cognition across groups (higher SRS, lower RMET scores). Those with higher 
glutamine levels made more errors when identifying emotions in the RMET task (r(10) = -0.77, p 
= 0.009), and also had more clinically significant scores on the SRS (r(10) = 0.87, p = 0.001).  
Conclusions:  Our results present evidence that glutamine levels measured within the ACC 
region are higher for adolescent males with ASD than age-matched HC males, and signal that 
GABA levels may also be decreased in this region. These changes are correlated with deficits in 
social cognition. 
